4Sturenburg E,Sobottka I,Noor D,et al.Evaluation of a New Cefepime-clavulanate ESBL Etest to Detect Extended-spectrum Beta-lactamases in an Enterobacteriaceae Strain Collection[J].Journal of Antimicrobial Chemotherapy,2004,54(1):134-138.
5Karen Bush,Georgea Jacoby,Antonea Medeiros.A Functional Classification Scheme for β-lactamases and Its Correlation with Molecular Structure[J].Antimicrob Agents Chemother,39:1211 -1233.
6Patrica A,Bradford.Extended-spectrum β-Lactamases in the 21st Century:Characterization,Epidemiology,and Detection of This Important Resistance Threat[J].Clinical MicrobiologI Reviews,2001:933-951
7National Committee for Clinical Laboratory Standards Performance Standards for Antimicrobial Susceptibilitiy Testing[S].Twelfth informational supplement.NCCLS,2002:46.
8Thomson K S,Sanders C C.Detection of Extended-spectrum β-lactamases in Members of the Family Enterobacteriaceae:Comparison of the Double Disk and Three Dimensional Tests[J].Anti microb Agents Chemother,1992,36:1877.
9Kliebe C,Nies B A,Meyer J F.Evolution of Plasmid-coded Resistance to Broad-spectrum Cephalosporins[J].Antimicrob Agents Chemother,1985,28:302-307.
10Fatima H Mzali,Aroonwadee Chanawong,KevinG Kerr.Detection of Extend-spectrum β-lactamas es in Member of the Family Enterobacteriaceae:Comparison of the MAST DD Test,the Double Disc and the Etest ESBL[J].Journal of Antimicrobial Chemotherapy,2000,45:881-885.
